<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Post-ischaemic silencing of p66 Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-04-22">22 April 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Spescha</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Molecular Cardiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<addrLine>Wagistrasse 12</addrLine>
									<postCode>CH-8952</postCode>
									<settlement>Schlieren</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Zurich Center for Integrative Human Physiology (ZIHP)</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Klohs</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institute for Biomedical Engineering</orgName>
								<orgName type="institution">Swiss Federal Institute of Technology Zurich (ETHZ)</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Semerano</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">San Raffaele Scientific Institute</orgName>
								<address>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Giacalone</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">San Raffaele Scientific Institute</orgName>
								<address>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Derungs</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Division of Psychiatry Research</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Schlieren</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Reiner</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Molecular Cardiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<addrLine>Wagistrasse 12</addrLine>
									<postCode>CH-8952</postCode>
									<settlement>Schlieren</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Zurich Center for Integrative Human Physiology (ZIHP)</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Rodriguez Gutierrez</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Molecular Cardiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<addrLine>Wagistrasse 12</addrLine>
									<postCode>CH-8952</postCode>
									<settlement>Schlieren</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">N</forename><surname>Mendez-Carmona</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Molecular Cardiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<addrLine>Wagistrasse 12</addrLine>
									<postCode>CH-8952</postCode>
									<settlement>Schlieren</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Glanzmann</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Molecular Cardiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<addrLine>Wagistrasse 12</addrLine>
									<postCode>CH-8952</postCode>
									<settlement>Schlieren</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Zurich Center for Integrative Human Physiology (ZIHP)</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Savarese</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Molecular Cardiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<addrLine>Wagistrasse 12</addrLine>
									<postCode>CH-8952</postCode>
									<settlement>Schlieren</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Zurich Center for Integrative Human Physiology (ZIHP)</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">N</forename><surname>Kra ¨nkel</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Molecular Cardiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<addrLine>Wagistrasse 12</addrLine>
									<postCode>CH-8952</postCode>
									<settlement>Schlieren</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Zurich Center for Integrative Human Physiology (ZIHP)</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Akhmedov</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Molecular Cardiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<addrLine>Wagistrasse 12</addrLine>
									<postCode>CH-8952</postCode>
									<settlement>Schlieren</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Zurich Center for Integrative Human Physiology (ZIHP)</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Keller</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Molecular Cardiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<addrLine>Wagistrasse 12</addrLine>
									<postCode>CH-8952</postCode>
									<settlement>Schlieren</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Zurich Center for Integrative Human Physiology (ZIHP)</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Mocharla</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Molecular Cardiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<addrLine>Wagistrasse 12</addrLine>
									<postCode>CH-8952</postCode>
									<settlement>Schlieren</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Zurich Center for Integrative Human Physiology (ZIHP)</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Kaufmann</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Zurich Center for Integrative Human Physiology (ZIHP)</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Institute of Physiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Wenger</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Zurich Center for Integrative Human Physiology (ZIHP)</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Institute of Physiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Vogel</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Institute of Veterinary Physiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Kulic</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Division of Psychiatry Research</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Schlieren</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Nitsch</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Division of Psychiatry Research</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Schlieren</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Beer</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">Cantonal Hospital of Baden</orgName>
								<address>
									<settlement>Baden</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Peruzzotti-Jametti</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">San Raffaele Scientific Institute</orgName>
								<address>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Sessa</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">San Raffaele Scientific Institute</orgName>
								<address>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Lu ¨scher</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Molecular Cardiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<addrLine>Wagistrasse 12</addrLine>
									<postCode>CH-8952</postCode>
									<settlement>Schlieren</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Zurich Center for Integrative Human Physiology (ZIHP)</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="institution" key="instit1">Cardiology</orgName>
								<orgName type="institution" key="instit2">University Heart Center</orgName>
								<orgName type="institution" key="instit3">University Hospital</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Camici</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Molecular Cardiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<addrLine>Wagistrasse 12</addrLine>
									<postCode>CH-8952</postCode>
									<settlement>Schlieren</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Zurich Center for Integrative Human Physiology (ZIHP)</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Post-ischaemic silencing of p66 Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-04-22">22 April 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">DFF85CA2EFC3B7882964DEB51A7B9464</idno>
					<idno type="DOI">10.1093/eurheartj/ehv175</idno>
					<note type="submission">Received 16 February 2015; revised 31 March 2015; accepted 6 April 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:25+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>Stroke † Ischaemia † Reperfusion † Free radicals † Endothelium Translational perspective</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Aim</head><p><s>Constitutive genetic deletion of the adaptor protein p66 Shc was shown to protect from ischaemia/reperfusion injury.</s><s>Here, we aimed at understanding the molecular mechanisms underlying this effect in stroke and studied p66 Shc gene regulation in human ischaemic stroke.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods and results</head><p><s>Ischaemia/reperfusion brain injury was induced by performing a transient middle cerebral artery occlusion surgery on wild-type mice.</s><s>After the ischaemic episode and upon reperfusion, small interfering RNA targeting p66 Shc was injected intravenously.</s><s>We observed that post-ischaemic p66 Shc knockdown preserved blood -brain barrier integrity that resulted in improved stroke outcome, as identified by smaller lesion volumes, decreased neurological deficits, and increased survival.</s><s>Experiments on primary human brain microvascular endothelial cells demonstrated that silencing of the adaptor protein p66 Shc preserves claudin-5 protein levels during hypoxia/reoxygenation by reducing nicotinamide adenine dinucleotide phosphate oxidase activity and reactive oxygen species production.</s><s>Further, we found that in peripheral blood monocytes of acute ischaemic stroke patients p66 Shc gene expression is transiently increased and that this increase correlates with short-term neurological outcome.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p><s>Post-ischaemic silencing of p66 Shc upon reperfusion improves stroke outcome in mice while the expression of p66 Shc gene correlates with short-term outcome in patients with ischaemic stroke.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>In light of the limited repertoire of therapeutical options available for the treatment of ischaemic stroke, the identification of novel potential targets is vital; in this respect, the present study demonstrates that the adaptor protein p66 Shc holds this potential as an adjunct therapy to thrombolysis.</s><s>Post-ischaemic silencing of p66 Shc protein yielded beneficial effects in a mouse model of I/R brain injury underlying an interesting</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Stroke is associated with major disabilities and mortality. <ref type="bibr" target="#b0">1</ref></s><s>Although over the last decades several novel experimental neuroprotective strategies have been developed, <ref type="bibr" target="#b1">2</ref> their translation into clinical practice has proven difficult. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b3">4</ref></s><s>Thus, the search for novel therapeutic targets for ischaemic stroke as an adjunct to thrombolysis remains an unmet clinical need.</s></p><p><s>Although ischaemic stroke is amenable to thrombolysis in patients presenting early after symptom onset, <ref type="bibr" target="#b4">5</ref> vascular leakage and the ensuing oedema formation during reperfusion contributes importantly to neurological deficits. <ref type="bibr" target="#b5">6</ref></s><s>Cerebral microvascular endothelial cells are a main component of the blood-brain barrier (BBB) <ref type="bibr" target="#b6">7</ref> which divides the cerebral circulation from brain tissue.</s><s>These cells are interconnected by tight and adherens junction proteins <ref type="bibr" target="#b6">7</ref> whose integrity is critical for stroke outcome. <ref type="bibr" target="#b7">8</ref></s><s>Indeed, disruption of the BBB following ischaemia/reperfusion (I/R) leads to vascular leakage and infiltration of plasma components into the brain tissue leading to oedema and further organ damage. <ref type="bibr">9 -11</ref></s><s>Overproduction of reactive oxygen species (ROS) following I/R is considered a key mechanism leading to BBB damage. 12</s><s>p66 Shc , an isoform of the mammalian adaptor protein Shc, <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b13">14</ref> is a crucial mediator of ROS production in several disease states <ref type="bibr">15 -18</ref> thereby leading to cellular apoptosis. <ref type="bibr">19 -21</ref></s><s>ndeed, much of the vasculoprotective properties observed by genetic deletion of p66 Shc in mice are the result of reduced oxidative stress and in turn preserved endothelial function. <ref type="bibr">15 -17</ref></s><s>n line with the above, we previously demonstrated that mice lacking p66 Shc develop smaller stroke size following I/R. <ref type="bibr" target="#b21">22</ref></s><s>However, the clinical relevance of this observation remains unknown and the underlying molecular mechanisms poorly understood.</s><s>To this end, we subjected mice to I/R brain injury and, to mimic real life clinical conditions as it would occur in the context of thrombolysis, we performed p66 Shc silencing in vivo using small interfering RNA (siRNA) after the ischaemic episode and upon reperfusion.</s><s>Additionally, we mimicked I/R conditions in primary human brain microvascular endothelial cells (HBMECs) by exposing them to hypoxia/reoxygenation (H/R) with and without silencing of p66 Shc and assessed the production of ROS as well as the levels of tight and adherens junction proteins.</s><s>Finally, we studied p66 Shc gene expression in peripheral blood monocytes (PBMs) of patients with acute ischaemic stroke and correlated it to the National Institutes of Health Stroke Scale (NIHSS).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods Patients</head><p><s>Twenty-seven patients admitted to the emergency room of San Raffaele Hospital (OSR, Milan, Italy) with a diagnosis of acute ischaemic stroke presenting within 6 h from symptom onset were enrolled.</s><s>Five patients presented wake-up stroke and were recruited within 6 h from awakening.</s><s>The initial diagnosis was based on clinical history, neurological examination (conducted by certified neurologists), and a brain computed tomography (CT) scan.</s><s>Nineteen sex-and age-matched healthy volunteers (either relatives or visitors of in-hospital patients), with a negative history of cardio-and cerebrovascular diseases, were included as controls.</s><s>Patients diagnosed with diabetes, systemic inflammatory diseases, acute infections, and malignancy were excluded, to eliminate potential interference of those disease states on p66 Shc expression. <ref type="bibr" target="#b22">23</ref></s><s>Blood was withdrawn from the antecubital vein at 6 and 24 h after initial stroke symptoms (for stroke patients), whereas control subjects donated blood once.</s></p><p><s>Of the 27 ischaemic stroke patients, 14 received thrombolytic treatment within 4.5 h from initial stroke symptoms onset.</s><s>Ischaemic strokes were clinically classified according to the Oxford Community Stroke Project classification (also known as the Bamford or OXFORD classification). <ref type="bibr" target="#b23">24</ref></s><s>Stroke aetiology was classified according to the Trial of ORG 10172 in Acute Stroke Treatment criteria. <ref type="bibr" target="#b24">25</ref></s><s>Moreover, stroke severity was assessed, using NIHSS on admission and at discharge.</s><s>Furthermore, delta NIHSS was calculated as the difference between the NIHSS presented at discharge and the NIHSS presented at admission (delta NIHSS ¼ NIHSS discharge 2 NIHSS admission); thereby, positive values indicate short-term neurologic worsening while negative values indicate neurological improvement.</s></p><p><s>The study was approved by the local Ethics Committee at San Raffaele Scientific Institute, Milan, Italy.</s><s>All participants (or their representative relatives) signed a written informed consent to authorize the treatment of their biological and clinical data.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Isolation of peripheral blood monocytes</head><p><s>Peripheral blood monocytes from whole blood were isolated using anti-CD14-coated MicroBeads (Miltenyi Biotec) on a magnetic separator (Miltenyi Biotec), as previously described. <ref type="bibr" target="#b25">26</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Animals</head><p><s>All animal experiments were performed on male, 11 -13-week-old wildtype (wt) (C57/BL6J) mice.</s><s>Study design and experimental protocols were approved by the Cantonal Veterinary Office of the Canton of Zurich.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Middle cerebral artery occlusion</head><p><s>A transient middle cerebral artery (MCA) occlusion (MCAO) surgery was performed on wt mice to induce I/R brain injury, as described. <ref type="bibr" target="#b21">22</ref></s><s>In brief, anaesthesia was induced with 3% isoflurane in oxygen-enriched air and mice were kept under 1.5% isoflurane anaesthesia during MCAO surgery.</s><s>Body temperature was controlled by using a warm water heating pad.</s><s>Incision site was infiltrated with 0.5% bupivacaine solution for pain relief.</s><s>A 6-0 silicone-coated filament (Doccol Corporation) was advanced into the internal carotid artery (ICA) until the thread occluded the origin of the left MCA to induce unilateral MCAO.</s><s>After 45 min (60 min for evaluation of long-term effect) of ischaemia, the thread was removed to allow reperfusion of the MCA.</s><s>After wound care and before returning to their standard cage, mice were kept for 1.5 h in a temperature controlled cage.</s><s>For sham operation, the filament was advanced into the ICA without occluding the MCA.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In vivo p66 Shc silencing</head><p><s>In vivo p66 Shc silencing was performed as described. <ref type="bibr" target="#b26">27</ref></s><s>Briefly, 1.6 nmol of predesigned siRNA targeting p66 Shc was incubated with a mixture of 150 mmol/L NaCl solution-jetPEI w and injected intravenously into the tail vein of the wt mouse randomized.</s><s>Scrambled siRNA was used as a negative control.</s><s>Detailed methods are provided in Supplementary material online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Magnetic resonance imaging</head><p><s>Lesion development was monitored after MCAO on a Bruker PharmaScan 47/16 (Bruker BioSpin GmbH) operating at 4.7 T. Anaesthesia was induced using 3% isoflurane (Abbott) in a 4 : 1 air-oxygen mixture.</s><s>During MRI acquisition, mice were kept under isoflurane anaesthesia (1.5%).</s><s>During the scan session, body temperature was monitored with a rectal temperature probe (MLT415, ADInstruments) and kept at 36 + 0.558C using a warm water circuit integrated into the animal support (Bruker BioSpin GmbH).</s><s>Magnetic resonance imaging (MRI) recordings were done in a blinded way by an independent person.</s></p><p><s>The lesion was determined on maps of the apparent diffusion coefficient (ADC) derived from diffusion-weighted images as areas of significant reduction of the ADC compared with the unaffected, contralateral side.</s><s>The lesion in the T2-weighted image was determined as hyperintense areas compared with the contralateral hemisphere.</s><s>Lesion volumes were quantified blinded by drawing regions of interest around the areas of reduced ADC and hyperintensities in T2-weighted images in five MRI slices using an ROI tool (Paravision, Bruker).</s><s>Brain infarct volumes were calculated by summing the volumes of each section and correcting for brain swelling, as described. <ref type="bibr" target="#b27">28</ref></s><s>Detailed methods are provided in Supplementary material online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Neurological deficits measurement</head><p><s>Neurological status was assessed using an adapted four-point scale test based on Bederson et al. <ref type="bibr" target="#b28">29</ref> and was graded as previously described <ref type="bibr" target="#b21">22</ref> : Grade 0: normal neurological function; Grade 1: forelimb flexion; Grade 2: circling; Grade 3: leaning to the contralateral side at rest; Grade 4: no spontaneous motor activity.</s><s>Motor performance was assessed using the RotaRod test.</s><s>Mice were placed on a rotating rod with increasing speed (4 -44 revolutions/min; circumference of the rod: 9 cm) and the latency to fall was measured.</s><s>The experimental trail was ended if the maximum rotation speed was achieved or if the mouse fell off the rod.</s><s>Per time point, three test runs per mouse were performed and the best run was included in the statistics.</s><s>Neurological deficit measurements were performed in a blinded way.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Evaluation of long-term effect</head><p><s>Long-term effect of post-ischaemic in vivo p66 Shc silencing on stroke was assessed up to 6 days.</s><s>The well-being of mice during the experimental period was determined using a score sheet that was approved by the Cantonal Veterinary Office of the Canton of Zurich.</s><s>This score sheet was used to define survival/death of an animal.</s><s>Death events include spontaneous deaths (4 of 16 for siScr stroke mice and 3 of 15 for sip66 Shc stroke mice) and mice which did not fulfil the health evaluation criteria.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Evans blue extravasation</head><p><s>Determination of BBB permeability after MCAO was done by evaluating Evans blue extravasation, as described. <ref type="bibr" target="#b29">30</ref></s><s>Detailed methods are provided in Supplementary material online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunofluorescence staining</head><p><s>Frozen brains were cut into 6 mm thick slices on a cryostat (Leica Cm 1900).</s><s>Immunofluorescent analysis was performed as described. <ref type="bibr" target="#b30">31</ref></s><s>iefly, brain slices were fixed in 4% paraformaldehyde and incubated with primary and secondary antibodies.</s><s>Images were taken using a Leica Dm4000 B microscope.</s><s>Stained area of claudin-5, vascular endothelial (VE)-cadherin, or occludin was measured using ImageJ Software and normalized to the total endothelial cell surface (assessed by isolectin B 4 staining).</s><s>Detailed methods are provided in Supplementary material online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RNA isolation and reverse transcription</head><p><s>Total RNA isolation and preparation of cDNA was performed as previously described. <ref type="bibr" target="#b25">26</ref></s><s>Total RNA of PBM, or of MCA, was extracted using TRIzol Reagent (Invitrogen).</s><s>Two micrograms (MCA) or 1 mg (PBM) of RNA was reverse transcribed using Ready-To-Go You-Prime First-Strand Beads (Amersham Biosciences) and first-strand random cDNA primers pd(N)6 (TaKaRa).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Real-time polymerase chain reaction</head><p><s>Determination of p66 Shc gene expression was done as previously described. <ref type="bibr" target="#b25">26</ref></s><s>Detailed methods are provided in Supplementary material online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture experiments</head><p><s>Primary HBMECs (Cell Systems) were cultured in EBM-2 medium supplied with EGM-2 bullet kit (Lonza).</s><s>Adhering cells (passages 5 -9) were grown to confluence and exposed to hypoxia (0.2% oxygen) for 4 h, followed or not by 4 h of incubation in a normoxic incubator (reoxygenation).</s><s>Hypoxia was induced using a gas-controlled glove box (Invivo2 400, Ruskinn Technologies).</s><s>In certain experiments, cells were pre-incubated with apocynin (0.1 mmol/L) (SAFC) for 1 h.</s><s>Thereafter, HBMECs were harvested for measuring superoxide anion (O −</s></p><p><s>2 ) production, nitric oxide (NO) bioavailability, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity or immunoblot analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Small interfering RNA transfection in human brain microvascular endothelial cells</head><p><s>Human brain microvascular endothelial cells were incubated with predesigned siRNA targeting p66 Shc at final concentration of 25 nmol/L using lipofectamine w RNAiMAX Reagent (Invitrogen), as previously described. <ref type="bibr" target="#b31">32</ref></s><s>etailed methods are provided in Supplementary material online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunoblotting</head><p><s>Basilar arteries and cells were lysed in lysis buffer and proteins were separated using SDS -PAGE, as previously described. <ref type="bibr" target="#b31">32</ref></s><s>Detailed methods are provided in Supplementary material online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measurement of O 2 2 production and nitric oxide bioavailability</head><p><s>Electron spin resonance spectroscopy was applied to determine O − 2 production and NO bioavailability, as described. <ref type="bibr">27,32 -34</ref></s><s>Detailed methods are provided in Supplementary material online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Nicotinamide adenine dinucleotide phosphate oxidase activity</head><p><s>Nicotinamide adenine dinucleotide phosphate oxidase activity was determined indirectly by measuring the ratio of NADP/NADPH using a commercially available kit (Abcam), according to the manufacturer's recommendations.</s><s>Post-ischaemic silencing of p66 Shc reduces ischaemia/reperfusion brain injury</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Statistical analysis for comparison of two groups was performed using two-tailed unpaired Student's t-test, or Mann-Whitney test, when appropriate.</s><s>For comparison of more than two unmatched groups, one-way analysis of variance (ANOVA) followed by Bonferroni post hoc test, or Kruskal -Wallis test followed by Dunn's post hoc test, when appropriate, was performed.</s><s>For comparison of groups with repeated measures, two-way ANOVA followed by Bonferroni post hoc test was applied.</s><s>Statistical analysis for survival studies was performed using log-rank (Mantel-Cox) test.</s><s>Pearson's correlation analysis was used to test the correlation between two quantitative variables, and Fisher's exact test for comparison of categorical data between study subjects.</s><s>Two-sided P-values were calculated and P , 0.05 denoted a significant difference.</s><s>Statistical analysis was performed using GraphPad Prism w software 5.01.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In vivo post-ischaemic silencing of p66 Shc reduces lesion volumes and improves functional outcome following I/R brain injury</head><p><s>To study the effect of post-ischaemic p66 Shc silencing on stroke, a transient MCAO surgery was performed on wt mice to induce I/R brain injury.</s><s>To analyse p66 Shc silencing efficiency in vivo beforehand, p66 Shc mRNA and protein levels were quantified in cerebral arteries (MCA and basilar artery, respectively).</s><s>Intravenous injection of siRNA against p66 Shc reduced mRNA and protein p66 Shc levels within 48 h after injection compared with siScr injection (Figure <ref type="figure" target="#fig_0">1A and B</ref>).</s><s>To localize the distribution of the p66 Shc siRNA within brain cerebral arteries, wt mice were injected with fluorescence dye-labelled p66 Shc siRNA (Alexa546-sip66 Shc ).</s><s>Flow cytometry with whole brain digests revealed a predominant uptake of the siRNA by the brain endothelium.</s><s>We observed that 21.2% of brain endothelial cells (CD45 2 CD31 + ) showed a positive signal for Alexa546-tagged p66 Shc siRNA (Figure <ref type="figure" target="#fig_0">1F</ref>) while only 0.6% of leukocytes (CD45 + CD31 2 ) (Figure <ref type="figure" target="#fig_0">1G</ref>) and 0.2% of other nucleated cells (CD45 2 CD31 2 ) (Figure <ref type="figure" target="#fig_0">1H</ref>) were positive for the Alexa546 signal.</s><s>Negative control was stained with Hoechst 33342 to label nucleated cells (Figure <ref type="figure" target="#fig_0">1L-N</ref>).</s></p><p><s>Lesion volumes in sip66 Shc and siScr injected stroke mice were quantified with MRI.</s><s>Diffusion-weighted imaging (DWI) denoted matching baseline lesion sizes in both groups after 45 min of ischaemia and directly upon reperfusion (Figure <ref type="figure" target="#fig_1">2B</ref>).</s><s>At 48 h post-MCAO, both DWI and T2-weighted imaging displayed instead a reduced stroke volume in sip66 Shc stroke mice when compared with siScr stroke mice (Figure <ref type="figure" target="#fig_1">2B and C</ref>).</s></p><p><s>Neurological deficits after MCAO were assessed using two different tests.</s><s>Pre-MCAO, both sip66 Shc and siScr stroke mice showed comparable performance in the RotaRod test and on the four-point scale test based on Bederson et al. <ref type="bibr" target="#b28">29</ref> (Figure <ref type="figure" target="#fig_1">2D and E</ref>).</s><s>At 24 h post-MCAO, we observed in both groups a reduced latency to fall in the RotaRod test.</s><s>However, at 48 h post-MCAO, sip66 Shc stroke mice showed a significant higher persistence on the rotating drum compared with siScr stroke mice (Figure <ref type="figure" target="#fig_1">2D</ref>).</s><s>In line with that, neurological deficits assessed with the scale test were significantly lower in sip66 Shc stroke mice compared with siScr stroke mice at 48 h post-MCAO (Figure <ref type="figure" target="#fig_1">2E</ref>).</s><s>All sham operated animas displayed normal neurological functions throughout the experimental period (Figure <ref type="figure" target="#fig_1">2D</ref> and data not shown).</s></p><p><s>By analysing the impact of p66 Shc silencing on stroke up to 6 days, we found an improved survival of sip66 Shc stroke mice when compared with siScr stroke mice (Figure <ref type="figure" target="#fig_1">2F</ref>, 31.25%</s><s>survival for siScr stroke mice vs. 66.66% for sip66 Shc stroke mice).</s><s>Survival was assessed in accordance to the health evaluation criteria approved by the Cantonal Veterinary Office of the Canton of Zurich; all sham operated animals survived and fulfilled the health evaluation criteria (data not shown).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In vivo p66 Shc silencing preserves blood -brain barrier integrity after I/R brain injury</head><p><s>The BBB plays a critical role for the outcome of stroke, <ref type="bibr" target="#b7">8</ref> and its permeability can be assessed in vivo by quantifying Evans blue extravasation. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b29">30</ref></s><s>We tested whether post-ischaemic p66 Shc silencing preserves BBB permeability after I/R brain injury in mice.</s><s>Indeed, 48 h post-MCAO p66 Shc silencing reduced Evans blue extravasation when compared with mice receiving siScr (Figure <ref type="figure" target="#fig_2">3A</ref>).</s></p><p><s>Blood-brain barrier permeability is regulated by tight and adherens junctional proteins connecting cerebral microvascular endothelial cells. <ref type="bibr" target="#b34">35</ref></s><s>Thus, we analysed the integrity of tight and adherens junctions following I/R brain injury focusing on claudin-5, occludin, and VE-cadherin.</s><s>Immunofluorescence staining of claudin-5 on coronal brain sections of siScr-treated stroke mice revealed decreased claudin-5-positive stained areas normalized to the total endothelial surface (measured by isolectin B 4 staining <ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b35">36</ref> ) in the ipsilateral hemisphere compared with the contralateral hemisphere (Figure <ref type="figure" target="#fig_2">3B</ref>), while this disruption of claudin-5 integrity was not observed in stroke mice receiving sip66 Shc (Figure <ref type="figure" target="#fig_2">3B</ref>).</s><s>Unlike claudin-5, occludin and VE-cadherin-positive stained areas were not changed following I/R brain injury in both experimental groups (data not shown).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Role of p66 Shc in H/R in primary human brain microvascular endothelial cells</head><p><s>In order to characterize the molecular regulation of claudin-5 by p66 Shc and to translate our in vivo murine data to human cells, we exposed HBMECs to hypoxia (H) alone, or hypoxia followed by reoxygenation (H/R).</s><s>Exposure of HBMECs to hypoxia neither altered phosphorylation of p66 Shc at Ser36, a critical step for its pro-apoptotic <ref type="bibr" target="#b36">37</ref> and pro-oxidant activity, <ref type="bibr" target="#b20">21</ref> nor total p66 Shc protein Post-ischaemic silencing of p66 Shc reduces ischaemia/reperfusion brain injury levels significantly, compared with normoxia (Figure <ref type="figure" target="#fig_3">4A</ref>).</s><s>In contrast, exposure to H/R increased phosphorylation of p66 Shc at Ser36 compared with normoxia (Figure <ref type="figure" target="#fig_3">4B</ref>).</s><s>Hypoxia-inducible factor-1a protein stabilization was used as an indicator of effective hypoxic conditions (Figure <ref type="figure" target="#fig_3">4A</ref>).</s><s>Reactive oxygen species and NO are critical for endothelial function <ref type="bibr" target="#b19">20</ref> and have been implicated in vascular permeability. <ref type="bibr" target="#b11">12</ref></s><s>Here, we analysed whether H/R regulates O − 2 production and NO bioavailability, and whether p66 Shc mediates these effects.</s><s>Exposure of HBMECs to H/R led to an increased O − 2 production (Figure <ref type="figure" target="#fig_3">4D</ref>) and a decreased NO bioavailability (Figure <ref type="figure" target="#fig_3">4E</ref>) compared with normoxia.</s><s>However, endothelial NO synthase (eNOS) phosphorylation at both sites studied (Ser1177 and Thr495) and eNOS protein expression remained unchanged (Figure <ref type="figure" target="#fig_3">4F and G</ref>).</s><s>Preincubation of HBMECs with p66 Shc siRNA, but not scrambled siRNA, reduced the increased O − 2 production (Figure <ref type="figure" target="#fig_3">4D</ref>) and increased the reduced NO bioavailability during H/R (Figure <ref type="figure" target="#fig_3">4E</ref>).</s><s>Nicotinamide adenine dinucleotide phosphate oxidase is considered as a major source of vascular O − 2 , <ref type="bibr" target="#b37">38</ref> and is a downstream target of p66 Shc . <ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b38">39</ref></s><s>Moreover, NADPH oxidase was demonstrated to play a dominant role in ROS production in brain endothelial cells exposed to H/R. <ref type="bibr" target="#b39">40</ref> Thus, we investigated whether during H/R NADPH oxidase is a source of O − 2 production downstream of p66 Shc .</s><s>Indeed, NADPH oxidase activity was increased after exposure to H/R, and returned to control levels after silencing of p66 Shc (Figure <ref type="figure" target="#fig_3">4H</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effect of p66 Shc and reactive oxygen species on claudin-5 in vitro</head><p><s>Human brain microvascular endothelial cells exposed to H/R exhibited reduced protein levels of claudin-5 compared with normoxia (Figure <ref type="figure" target="#fig_4">5A</ref>).</s><s>In contrast, occludin and VE-cadherin protein levels were not affected by exposure to H/R (Figure <ref type="figure" target="#fig_4">5B and C</ref>).</s><s>After both, pre-incubation of HBMECs with p66 Shc siRNA and with the antioxidant apocynin <ref type="bibr" target="#b40">41</ref> claudin-5 levels were elevated under H/R condition (Figure <ref type="figure" target="#fig_4">5D and E</ref>). 2 production (n ¼ 12 -13) that is blunted after silencing of p66 Shc (n ¼ 7 -13).</s><s>(E) Human brain microvascular endothelial cells exposed to H/R show a reduced nitric oxide bioavailability (n ¼ 12) that is elevated after p66 Shc silencing (n ¼ 6 -12).</s><s>(F and G) H/R does not alter phosphorylation of endothelial NO synthase at both sites studied (Ser1177 and Thr495) and endothelial NO synthase protein expression compared with normoxia (n ¼ 7).</s><s>(H ) Pre-incubation of human brain microvascular endothelial cells with p66 Shc small interfering RNA reduces H/R-increased nicotinamide adenine dinucleotide phosphate oxidase activity (n ¼ 11).</s><s>Data are expressed as mean + s.e.m. *P , 0.05, **P , 0.01, ***P , 0.001 for H/R vs. normoxia; # P , 0.05, ## P , 0.01 for H/R with sip66 Shc vs. H/R.</s><s>p66 Shc gene expression is increased in patients with ischaemic stroke and correlates to neurological outcome To provide evidence for a role of p66 Shc in human ischaemic stroke, we analysed p66 Shc expression in PBMs of patients with ischaemic stroke.</s><s>A total of 27 ischaemic stroke patients and 19 age-and sexmatched, healthy control subjects were recruited.</s><s>Clinical characteristics of both groups did not differ statistically (Table <ref type="table" target="#tab_0">1</ref>).</s><s>p66 Shc mRNA levels were significantly increased 6 h after initial stroke symptoms (Figure <ref type="figure" target="#fig_6">6A</ref>) and returned to control levels 24 h thereafter (Figure <ref type="figure" target="#fig_6">6A</ref>).</s><s>Of note, p66 Shc gene expression at 6 h was comparable in patients with ischaemic stroke regardless of whether they had received thrombolytic treatment or not (Figure <ref type="figure" target="#fig_6">6B</ref>).</s><s>p66 Shc transcript levels of all study subjects positively correlated with neurological deficits at admission, measured according to the NIHSS (Figure <ref type="figure" target="#fig_6">6C</ref>).</s><s>Importantly, while p66 Shc gene expression of stroke patients which did not receive thrombolytic intervention did not correlate with shortterm neurological outcome (NIHSS discharge 2 NIHSS admission) (Figure <ref type="figure" target="#fig_6">6D</ref>), it positively correlated in stroke patients treated with thrombolysis (Figure <ref type="figure" target="#fig_6">6E</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In this study, we demonstrate for the first time that post-ischaemic p66 Shc silencing reduces brain injury by preserving BBB integrity by preventing claudin-5 level downregulation.</s><s>The in vivo findings in the mouse were translated to HBMECs exposed to H/R where p66 Shc was phosphorylated at Ser36 leading to the reduction in claudin-5 levels via activation of the NADPH oxidase and increased ROS production.</s><s>Further, we show that p66 Shc expression is increased in PBMs of patients with ischaemic stroke within 6 h from onset of symptoms and that p66 Shc gene expression correlates to short-term neurological outcome.</s></p><p><s>In mice, we recently showed that constitutive genetic deletion of p66 Shc reduces early stroke size and neurological deficits following I/R brain injury. <ref type="bibr" target="#b21">22</ref></s><s>However, the mechanisms of this effect and its clinical relevance remained elusive.</s><s>Furthermore, the use of constitutive knockout animals only serves as a proof-of-principle and does not allow delineation of therapeutic time windows as required in the clinical setting.</s><s>In contrast, RNA interference (RNAi)-based strategies allow to modify the expression of a certain target at the posttranscriptional level, thus making it therapeutically interesting. <ref type="bibr" target="#b41">42</ref></s><s>ndeed, several RNAi-based strategies are under investigation in clinical trials. <ref type="bibr" target="#b42">43</ref></s><s>Here, we used a clinically relevant experimental setup with siRNA delivery upon reperfusion to reduce p66 Shc levels.</s><s>Reperfusion of an occluded vessel allows reoxygenation of the ischaemic area which promotes recovery of penumbral areas. <ref type="bibr" target="#b43">44</ref></s><s>evertheless paradoxically, re-introduction of oxygen in a previously ischaemic area also causes a surge in free radical generation <ref type="bibr" target="#b10">11</ref> which interferes with the recovery processes.</s><s>Indeed, we demonstrate here that silencing of the pro-oxidant p66 Shc after the ischaemic episode and upon reperfusion, as it would be the case in stroke patients presenting at the emergency room undergoing thrombolytic treatment, reduces lesion volume, improves neurological function, and increases survival.</s><s>These data highlight the potential of p66 Shc as novel therapeutic target in stroke patients undergoing thrombolysis.</s></p><p><s>Given the key role of BBB permeability in determining stroke outcome, <ref type="bibr" target="#b5">6</ref> we characterized its integrity by analysing Evans blue extravasation, a known indicator for vascular leakage. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b44">45</ref></s><s>Indeed, and in line with the improved stroke outcome in the sip66 Shc stroke mice, BBB disruption was blunted after p66 Shc silencing compared with control mice.</s><s>Cerebral microvascular endothelial cells connected via tight and adherens junctional proteins make up the BBB. <ref type="bibr" target="#b6">7</ref></s><s>A disruption of this tightly regulated structure is known to occur in I/R brain injury and is responsible for vascular leakage and in turn oedema formation. <ref type="bibr">9 -11</ref></s><s>To investigate the molecular mechanisms by which p66 Shc preserves BBB integrity after I/R brain injury, we focused in vivo as well as in vitro on claudin-5, occludin and VE-cadherin, three major junctional proteins. <ref type="bibr" target="#b6">7</ref></s><s>  found less reduction in claudin-5 levels after silencing of p66 Shc .</s><s>In contrast, occludin and VE-cadherin levels remained unaltered in both experimental settings.</s><s>Our data obtained on murine as well as primary human cells indicate that p66 Shc mediates BBB disruption by acting specifically on claudin-5 rather than occludin and VE-cadherin.</s></p><p><s>To characterize the molecular regulation of claudin-5 by p66 Shc , we exposed primary HBMECs to H/R, to mimic in vivo settings.</s><s>Exposure of HBMECs to H/R, but not to hypoxia, increased phosphorylation of p66 Shc at Ser36 confirming previous data in renal tubular epithelial cells. <ref type="bibr" target="#b45">46</ref></s><s>Together with our in vivo data, these results suggest that p66 Shc is mainly involved in mediating its deleterious effects during reperfusion, rather than during ischaemia.</s><s>Endothelial ROS production and NO bioavailability are both critical for I/ R-induced alteration in BBB permeability and stroke outcome <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b46">47</ref> and ROS are known to influence claudin-5 levels in brain endothelial cells. <ref type="bibr" target="#b47">48</ref></s><s>Here, we demonstrate in vitro evidence that endothelial p66 Shc silencing in H/R preserves NO bioavailability, reduces NADPH oxidase activation, and decreases ROS generation thus blunting the reduction in claudin-5 levels.</s><s>This pathway may be also relevant in vivo.</s></p><p><s>To study p66 Shc gene regulation in stroke patients, we performed proof-of-principle experiments assessing its expression in PBMs of acute ischaemic stroke patients.</s><s>Although it would be of particular interest and relevance to elucidate the role of cerebrovascular p66 Shc in stroke patients, sample collection in humans would prove extremely difficult thus, we selected PBMs since those are easily obtainable from whole blood and could still give us interesting insights into gene expression changes.</s><s>Here we found that p66 Shc mRNA levels were increased 6 h after initial stroke symptoms and then returned to basal levels at 24 h.</s><s>Moreover, p66 Shc expression at 6 h correlated to short-term neurological outcome (delta NIHSS) in stroke patients.</s><s>Interestingly, delta NIHSS correlated to p66 Shc expression only in patients undergoing thrombolysis, but not in those without.</s><s>Although thrombolysis is known to improve neurological outcome after stroke, <ref type="bibr" target="#b4">5</ref> it is also associated with early reperfusion-induced BBB damage <ref type="bibr" target="#b48">49</ref> which is known to be mediated by ROS and affects stroke outcome. <ref type="bibr" target="#b5">6</ref></s><s>An increased vascular leakage also favours the accumulation of blood circulating cells in brain tissue thus causing tissue damage via production of free radicals. <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b49">50</ref></s><s>his could explain why the correlation between neurological outcome and p66 Shc expression is found only in thrombolytic patients where monocytic p66 Shc -induced ROS production and the consequent damage is likely more pronounced.</s><s>In contrast, in patients not undergoing thrombolysis, the role of reperfusioninduced ROS-dependent injury is less prominent and thus neurological damage is less likely to be dependent on p66 Shc -mediated ROS.</s><s>In summary, the present study sets the stage for follow-up clinical studies aimed at assessing the potential for p66 Shc to become a novel therapeutic target as an adjunct of thrombolysis for the management of acute ischaemic stroke.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1</head><label>1</label><figDesc><div><p><s>Figure 1 In vivo silencing of p66 Shc .</s><s>(A) Real-time polymerase chain reaction reveals reduced p66 Shc levels in middle cerebral artery homogenates 24 h (n ¼ 5 -6) and 48 h (n ¼ 7 -8) after p66 Shc small interfering RNA injection compared with scrambled small interfering RNA injection (siScr).</s><s>Data are expressed as mean + s.e.m. *P , 0.05 for sip66 Shc vs. siScr.</s><s>(B) Immunoblot analysis confirms silencing of p66 Shc in basilar arteries within 48 h after p66 Shc small interfering RNA injection (representative immunoblot of at least five animals per group).</s><s>(C-N) Flow cytometry analysis of brain single cell suspensions 24 h after injection of Alexa546-sip66 Shc (upper panel) when compared with negative control (lower panel).</s><s>Singlets (C and I ) with nuclei (D and J ) were plotted in a dot plot of APC (CD45) vs. AlexaFluor488 (CD31) to distinguish endothelial cells (CD45 2 CD31 + ), leukocytes (CD45 + CD31 2 ), as well as other cell types (CD45 2 CD31 2 ) (E and K ).</s><s>Histogramms show Alexa546fluorescence representing content of Alexa546-sip66 Shc in endothelial cells (F and L), leukocytes (G and M), and other cell types (H and N ).</s></p></div></figDesc><graphic coords="4,81.58,102.44,626.54,324.11" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2</head><label>2</label><figDesc><div><p><s>Figure 2 Impact of post-ischaemic in vivo p66 Shc silencing on stroke outcome.</s><s>(A) Schematic of experimental study design.</s><s>Upon reperfusion, specific small interfering RNA against p66 Shc is injected intravenously in wt mice, and development of lesion and functional deficits were characterized.</s><s>(B and C) Both, DWI and T2-weighted imaging denote reduced lesions in sip66 Shc stroke mice (DWI: n ¼ 5; T2: n ¼ 6) compared with siScr stroke mice (n ¼ 7) at 48 h post-MCAO.</s><s>(D and E) Evaluation of neurological deficits by using the RotaRod test and a four-point scale test based on Bederson et al. 28 Both neurological tests demonstrate less neurological deficits in the sip66 Shc stroke group (n ¼ 9) compared with the siScr stroke group (RotaRod: n ¼ 7; Bederson: n ¼ 8).</s><s>All sham operated animals show normal neurological function throughout the experimental period (n ¼ 5 -6).</s><s>(F ) Post-ischaemic silencing of p66 Shc increases survival of mice after stroke (n ¼ 15 -16).</s><s>Data are expressed as mean + s.e.m. *P , 0.05, **P , 0.01 for sip66 Shc stroke vs. siScr stroke.</s></p></div></figDesc><graphic coords="5,60.32,372.42,470.21,257.78" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 p66</head><label>3</label><figDesc><div><p><s>Figure 3 p66 Shc mediates blood-brain barrier disruption after I/R brain injury.</s><s>(A) Assessment of blood-brain barrier impairment.</s><s>p66 Shc silenced mice (n ¼ 6) show less Evans blue extravasation compared with siScr stroke mice (n ¼ 5) at 48 h of reperfusion.</s><s>(B) Representative fluorescence microscopy images of claudin-5 and isolectin B 4 (endothelial marker) stained brain sections.</s><s>Following I/R brain injury, claudin-5-positive stained area normalized to the total endothelial surface is reduced in the ipsilateral hemisphere compared with the contralateral hemisphere in siScr stroke mice (n ¼ 5), but not in sip66 Shc stroke mice (n ¼ 5).</s><s>Scale bar, 35 mm.</s><s>Data are presented as mean + s.e.m. *P , 0.05 for siScr stroke ipsilateral vs. siScr stroke contralateral; **P , 0.01 for sip66 Shc stroke vs. siScr stroke.</s></p></div></figDesc><graphic coords="6,65.03,409.72,470.21,242.53" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4 p66</head><label>4</label><figDesc><div><p><s>Figure 4 p66 Shc mediates H/R-induced damage of human brain microvascular endothelial cells.</s><s>(A) p66 Shc activation remains unchanged after exposure of human brain microvascular endothelial cells to hypoxia compared with normoxia (n ¼ 8).</s><s>Hypoxia-inducible factor-1a stabilization is used as an indicator for effective hypoxic condition.</s><s>(B) Hypoxia followed by reoxygenation increases phosphorylation of p66 Shc at Ser36 compared with normoxia (n ¼ 6).</s><s>(C ) Representative immunoblot of p66 Shc silencing in vitro.</s><s>Pre-incubation of human brain microvascular endothelial cells with p66 Shc small interfering RNA selectively reduces p66 Shc levels, without affecting the levels of the two other Shc isoforms p52 Shc and p46 Shc .</s><s>(D) H/R leads to an increased O − 2 production (n ¼ 12 -13) that is blunted after silencing of p66 Shc (n ¼ 7 -13).</s><s>(E) Human brain microvascular endothelial cells exposed to H/R show a reduced nitric oxide bioavailability (n ¼ 12) that is elevated after p66 Shc silencing (n ¼ 6 -12).</s><s>(F and G) H/R does not alter phosphorylation of endothelial NO synthase at both sites studied (Ser1177 and Thr495) and endothelial NO synthase protein expression compared with normoxia (n ¼ 7).</s><s>(H ) Pre-incubation of human brain microvascular endothelial cells with p66 Shc small interfering RNA reduces H/R-increased nicotinamide adenine dinucleotide phosphate oxidase activity (n ¼ 11).</s><s>Data are expressed as mean + s.e.m. *P , 0.05, **P , 0.01, ***P , 0.001 for H/R vs. normoxia; # P , 0.05, ## P , 0.01 for H/R with sip66 Shc vs. H/R.</s></p></div></figDesc><graphic coords="7,60.32,75.01,470.21,276.89" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 5</head><label>5</label><figDesc><div><p><s>Figure 5 Effect of p66 Shc silencing and reactive oxygen species on H/R-decreased claudin-5 expression.</s><s>(A) Immunoblot analysis reveals decreased claudin-5 protein levels after exposure of human brain microvascular endothelial cells to H/R (n ¼ 7), but not of occludin (n ¼ 5) (B) and vascular endothelial-cadherin (n ¼ 7) (C).</s><s>Pre-incubation with p66 Shc small interfering RNA (n ¼ 7) (D), or apocynin (0.1 mmol/L) (n ¼ 6) (E), increases claudin-5 levels under H/R condition.</s><s>Data are presented as mean + s.e.m. **P , 0.01, ***P , 0.001 for H/R vs. normoxia; # P , 0.05, ## P , 0.01 for H/R with sip66 Shc or apocynin vs. H/R.</s></p></div></figDesc><graphic coords="8,131.13,75.01,337.74,335.40" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head></head><label></label><figDesc><div><p><s>Consistently, we .... ............ ............ ............ ............ ........... ............ ............ ............ ........... ............ ............ ............ ........... ............ ...... .... ............ ............ ............ ............ ........... ............ ............ ............ ........... ............ ............ ............ ........... ............ ...... .... ............ ............ ............ ............ ........... ............ ............ ............ ........... ............ ............ ............ ........... ............ ......</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 6 p66</head><label>6</label><figDesc><div><p><s>Figure 6 p66 Shc gene expression in PBMs of ischaemic stroke patients.</s><s>(A) Real-time polymerase chain reaction determined increased p66 Shc mRNA levels in stroke patients 6 h (n ¼ 27), but not 24 h (n ¼ 16) after initial stroke symptoms compared with the levels of control subjects (n ¼ 19).</s><s>Data are expressed as mean + s.e.m. (B) p66 Shc gene expression 6 h after initial stroke symptoms was determined in sub-groups of stroke patients according as they did (t-PA), or did not (w/o t-PA) receive thrombolytic treatment.</s><s>Values from controls are also shown for comparisons.</s><s>p66 Shc mRNA levels are not different between both stroke sub-groups (w/o t-PA: n ¼ 13; t-PA: n ¼ 14).</s><s>Both sub-groups show higher p66 Shc levels compared with controls.</s><s>Data are expressed as mean + s.e.m. (C ) Correlation between p66 Shc gene expression and NIHSS at admission of all study subjects (n ¼ 46).</s><s>(D and E) Correlation analysis of p66 Shc transcripts and delta NIHSS (NIHSS discharge 2 NIHSS admission) in w/o t-PA patients (n ¼ 13) and in t-PA patients (n ¼ 14).</s><s>For (C-E) linear regression trend lines are illustrated.</s><s>***P , 0.001.</s><s>NIHSS, National Institutes of Health Stroke Scale; t-PA, tissue plasminogen activator.</s></p></div></figDesc><graphic coords="10,65.03,75.01,470.21,241.06" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Characteristics of clinical study population</s></p></div></figDesc><table><row><cell>Study population</cell><cell>Controls n 5 19</cell><cell>Stroke patients n 5 27</cell><cell>P-value</cell><cell></cell></row><row><cell>Age (years) mean (range)</cell><cell>71.8 (63-83)</cell><cell>73.9 (52-90)</cell><cell>0.42</cell><cell></cell></row><row><cell>Female, n (%)</cell><cell>10 (52.6%)</cell><cell>15 (55.6%)</cell><cell>1.0</cell><cell></cell></row><row><cell>Smoking, n (%)</cell><cell>1 (5.3%)</cell><cell>6 (22.2%)</cell><cell>0.22</cell><cell></cell></row><row><cell>Hypertension, n (%)</cell><cell>10 (52.6%)</cell><cell>15 (55.6%)</cell><cell>1.0</cell><cell></cell></row><row><cell>Dyslipidaemia, n (%)</cell><cell>2 (10.5%)</cell><cell>4 (14.8%)</cell><cell>1.0</cell><cell></cell></row><row><cell>Atrial fibrillation, n (%)</cell><cell>0</cell><cell>4 (14.8%)</cell><cell>0.13</cell><cell></cell></row><row><cell>Coronary artery disease, n (%)</cell><cell>0</cell><cell>5 (18.5%)</cell><cell>0.07</cell><cell></cell></row><row><cell>Previous stroke/TIA, n (%)</cell><cell>0</cell><cell>4 (14.8%)</cell><cell>0.13</cell><cell></cell></row><row><cell>Peripheral artery disease, n (%)</cell><cell>0</cell><cell>4 (14.8%)</cell><cell>0.13</cell><cell></cell></row><row><cell>Stroke sub-groups</cell><cell></cell><cell>tPA n ¼ 14 (51.9%)</cell><cell>w/o tPA n ¼ 13 (48.1%)</cell><cell>P-value</cell></row><row><cell>Age (years) mean (range)</cell><cell></cell><cell>69.4 (52-80)</cell><cell>78.6 (64-90)</cell><cell>0.03</cell></row><row><cell>Female, n (%)</cell><cell>15 (55.6%)</cell><cell>6</cell><cell>9</cell><cell>0.25</cell></row><row><cell>OXFORD classification</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>TACI, n (%)</cell><cell>12 (44.4%)</cell><cell>4</cell><cell>8</cell><cell>0.12</cell></row><row><cell>PACI, n (%)</cell><cell>10 (37.0%)</cell><cell>7</cell><cell>3</cell><cell>0.24</cell></row><row><cell>LACI, n (%)</cell><cell>5 (18.5%)</cell><cell>3</cell><cell>2</cell><cell>1.0</cell></row><row><cell>POCI, n (%)</cell><cell>0</cell><cell>0</cell><cell>0</cell><cell></cell></row><row><cell>TOAST classification</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Large vessels atherosclerosis, n (%)</cell><cell>5 (18.5%)</cell><cell>2</cell><cell>3</cell><cell>0.65</cell></row><row><cell>Card ioembolism, n (%)</cell><cell>13 (48.1%)</cell><cell>6</cell><cell>7</cell><cell>0.71</cell></row><row><cell>Small vessels disease, n (%)</cell><cell>1 (3.7%)</cell><cell>1</cell><cell>0</cell><cell>1.0</cell></row><row><cell>Undetermined cause, n (%)</cell><cell>5 (18.5%)</cell><cell>3</cell><cell>2</cell><cell>1.0</cell></row><row><cell>Other cause, n (%)</cell><cell>3 (11.1%)</cell><cell>2</cell><cell>1</cell><cell>1.0</cell></row><row><cell>Stroke severity assessment</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Admission NIHSS, mean (SD)</cell><cell>13.3 (6.7)</cell><cell>12.1 (5.0)</cell><cell>14.5 (8.1)</cell><cell>0.38</cell></row><row><cell>Discharge NIHSS, mean (SD)</cell><cell>10.1 (9.9)</cell><cell>5.8 (5.3)</cell><cell>14.8 (11.9)</cell><cell>0.046</cell></row><row><cell>Early complications</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Haemorrhagic transformation, n (%) a</cell><cell>4 (17.4%)</cell><cell>3</cell><cell>1</cell><cell>0.61</cell></row><row><cell>Cerebral oedema, n (%) a</cell><cell>6 (26.1%)</cell><cell>1</cell><cell>5</cell><cell>0.05</cell></row></table><note><p><s>Clinical characteristics of controls and stroke patients do not differ statistically.</s><s>Sub-group analysis shows statistically significant differences in age and NIHSS at discharge between patients treated with thrombolysis and patients which did not receive thrombolysis.</s><s>Age is given as mean (with ranges) and NIHSS is expressed as mean + SD.</s><s>TIA, transient ischaemic attack; tPA, tissue plasminogen activator; TACI, total anterior circulation infarct; PACI, partial anterior circulation infarct; LACI, lacunar infarct; POCI, posterior circulation infarct; TOAST, Trial of ORG 10172 in Acute Stroke Treatment; NIHSS, National Institutes of Health Stroke Scale.</s><s>a Haemorrhagic transformation and cerebral oedema were determined in stroke patients (n ¼ 23; tPA n ¼ 13, w/otPA n ¼ 10) on CT scan at 24 h after initial stroke symptoms.</s></p></note></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We thank Prof. Gianvito Martino from the Neuroimmunology Unit, Division of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute Milan, Italy, for his intellectual and technical contribution.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary material</head><p><s>Supplementary Material is available at European Heart Journal online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>This work was supported by the Swiss National Science Foundation (grant number 310030_147017 to G.G.C., 310030-135815 to T.F.L., and 136822 to J.K.) and Helmut-Horten Foundation to G.G.C.</s></p><p><s>Conflict of interest: none declared.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Cardiovascular disease in Europe 2014: epidemiological update</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nichols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Townsend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Scarborough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rayner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="2950" to="2959" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">1,026 experimental treatments in acute stroke</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">E</forename><surname>O'collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Macleod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Donnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Horky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Van Der Worp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Howells</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="467" to="477" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Update of the stroke therapy academic industry roundtable preclinical recommendations</title>
		<author>
			<persName><forename type="first">M</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Feuerstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Howells</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Hurn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Kent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Savitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Lo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Group</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="2244" to="2250" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Angiopoietin-like 4 and ischaemic stroke: a promising start</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Spescha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sessa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Camici</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="3603" to="3605" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke RT-PA stroke study group</title>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">333</biblScope>
			<biblScope unit="page" from="1581" to="1587" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Development, maintenance and disruption of the blood-brain barrier</title>
		<author>
			<persName><forename type="first">B</forename><surname>Obermeier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Daneman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Ransohoff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1584" to="1596" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The blood-brain barrier in health and chronic neurodegenerative disorders</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">V</forename><surname>Zlokovic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="178" to="201" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">The immunology of stroke: from mechanisms to translation</title>
		<author>
			<persName><forename type="first">C</forename><surname>Iadecola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Anrather</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="796" to="808" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fredriksson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Geyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Folestad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Andrae</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Pietras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yepes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Strickland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Betsholtz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Eriksson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Lawrence</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="731" to="737" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Mechanisms, challenges and opportunities in stroke</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Lo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dalkara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Moskowitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Neurosci</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="399" to="415" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Rodrigues</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Granger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Res</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="291" to="299" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The science of stroke: mechanisms in search of treatments</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Moskowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Lo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Iadecola</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="181" to="198" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction</title>
		<author>
			<persName><forename type="first">G</forename><surname>Pelicci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lanfrancone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Grignani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcglade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cavallo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Forni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nicoletti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Grignani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Pelicci</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="93" to="104" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway</title>
		<author>
			<persName><forename type="first">E</forename><surname>Migliaccio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Salcini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pelicci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Superti-Furga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Fiore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Lanfrancone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pelicci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="706" to="716" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Camici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schiavoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Francia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bachschmid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Martin-Padura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hersberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Tanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pelicci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Volpe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Anversa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Luscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cosentino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="5217" to="5222" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Deletion of p66shc gene protects against age-related endothelial dysfunction</title>
		<author>
			<persName><forename type="first">P</forename><surname>Francia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Delli Gatti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bachschmid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Martin-Padura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Savoia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Migliaccio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Pelicci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schiavoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Luscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Volpe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cosentino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="2889" to="2895" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet</title>
		<author>
			<persName><forename type="first">C</forename><surname>Napoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Martin-Padura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>De Nigris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Giorgio</forename><forename type="middle">M</forename><surname>Mansueto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Somma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Condorelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Rosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pelicci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="2112" to="2116" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">p66ShcA modulates tissue response to hindlimb ischemia</title>
		<author>
			<persName><forename type="first">G</forename><surname>Zaccagnini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Martelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fasanaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Magenta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gaetano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Carlo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Biglioli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Giorgio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Martin-Padura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Pelicci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Capogrossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="2917" to="2923" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">p66(Shc) protein, oxidative stress, and cardiovascular complications of diabetes: the missing link</title>
		<author>
			<persName><forename type="first">P</forename><surname>Francia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cosentino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schiavoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Perna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Camici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Luscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Volpe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Med</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="885" to="891" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Anti-aging medicine: molecular basis for endothelial cell-targeted strategies -a mini-review</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Camici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cosentino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Francia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Luscher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gerontology</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="101" to="108" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein</title>
		<author>
			<persName><forename type="first">F</forename><surname>Cosentino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Francia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Camici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Pelicci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Luscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Volpe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="622" to="628" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Deletion of the ageing gene p66(Shc) reduces early stroke size following ischaemia/reperfusion brain injury</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Spescha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wegener</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Wyss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lauinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tabatabai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Paneni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cosentino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Weller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Nitsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Luscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Camici</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="96" to="103" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress</title>
		<author>
			<persName><forename type="first">E</forename><surname>Pagnin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Fadini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>De Toni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tiengo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Calo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Avogaro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="1130" to="1136" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Classification and natural history of clinically identifiable subtypes of cerebral infarction</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bamford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sandercock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dennis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Burn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Warlow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">337</biblScope>
			<biblScope unit="page" from="1521" to="1526" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Adams</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Bendixen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Kappelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Biller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Love</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Gordon</surname></persName>
		</author>
		<author>
			<persName><surname>Marsh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="35" to="41" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Expression of the aging gene p66Shc is increased in peripheral blood monocytes of patients with acute coronary syndrome but not with stable coronary artery disease</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Franzeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Spescha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hasun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Akhmedov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Steffel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cosentino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Tanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Von Eckardstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Maier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Luscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Wyss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Camici</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Atherosclerosis</title>
		<imprint>
			<biblScope unit="volume">220</biblScope>
			<biblScope unit="page" from="282" to="286" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes</title>
		<author>
			<persName><forename type="first">F</forename><surname>Paneni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mocharla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Akhmedov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Costantino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Osto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Volpe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Luscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cosentino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="278" to="289" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">A semiautomated method for measuring brain infarct volume</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Swanson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Morton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tsao-Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Savalos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Davidson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Sharp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cereb Blood Flow Metab</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="290" to="293" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Bederson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Pitts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tsuji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Nishimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bartkowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="472" to="476" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Gursoy-Ozdemir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bolay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Saribas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dalkara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<date type="published" when="1974">2000. 1974. 1980</date>
		</imprint>
	</monogr>
	<note>discussion 1981</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Protective effects of angiopoietin-like 4 on cerebrovascular and functional damages in ischaemic stroke</title>
		<author>
			<persName><forename type="first">C</forename><surname>Bouleti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mathivet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Coqueran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Serfaty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lesage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Berland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ardidie-Robouant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kauffenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Henrion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lapergue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mazighi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Duyckaerts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Thurston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Valenzuela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Yancopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Monnot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Margaill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Germain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="3657" to="3668" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Adaptor protein p66Shc mediates hypertension-associated, cyclic stretch-dependent, endothelial damage</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Spescha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Glanzmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Simic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Witassek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Akhmedov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Tanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Luscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Camici</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="347" to="353" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease</title>
		<author>
			<persName><forename type="first">C</forename><surname>Besler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Heinrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Rohrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Doerries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Riwanto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Shih</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chroni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yonekawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Schaefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Akhmedov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Daniil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Manes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Templin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wyss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Maier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Tanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Matter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Corti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Furlong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Lusis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Von Eckardstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Fogelman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Luscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Landmesser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="2693" to="2708" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Oxidized low-density lipoprotein activates p66Shc via lectin-like oxidized lowdensity lipoprotein receptor-1, protein kinase C-beta, and c-Jun N-terminal kinase kinase in human endothelial cells</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cosentino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Camici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Akhmedov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Vanhoutte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Tanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Luscher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="2090" to="2097" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Modelling of the blood-brain barrier in drug discovery and development</title>
		<author>
			<persName><forename type="first">R</forename><surname>Cecchelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Berezowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lundquist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Culot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Renftel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Dehouck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fenart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Drug Discov</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="650" to="661" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Nogo-A is a negative regulator of CNS angiogenesis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Walchli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pernet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Weinmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Shiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Guzik-Kornacka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Decrey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Yuksel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vogel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Ingber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Vogel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Frei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Schwab</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="E1943" to="E1952" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">The p66shc adaptor protein controls oxidative stress response and life span in mammals</title>
		<author>
			<persName><forename type="first">E</forename><surname>Migliaccio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Giorgio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pelicci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Reboldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Pandolfi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lanfrancone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Pelicci</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">402</biblScope>
			<biblScope unit="page" from="309" to="313" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Drummond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Selemidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Griendling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Sobey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Drug Discov</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="453" to="471" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Decreased superoxide production in macrophages of long-lived p66Shc knock-out mice</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Tomilov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Bicocca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Schoenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Giorgio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Migliaccio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Ramsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hagopian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Pelicci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Cortopassi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="page" from="1153" to="1165" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Moderate hypoxia followed by reoxygenation results in blood-brain barrier breakdown via oxidative stress-dependent tight-junction protein disruption</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Zehendner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Librizzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hedrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Angamo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>De Curtis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Luhmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e82823</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant</title>
		<author>
			<persName><forename type="first">S</forename><surname>Heumuller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wind</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Barbosa-Sicard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Busse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schroder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Brandes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="211" to="217" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Revealing the world of RNA interference</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Mello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Conte</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">431</biblScope>
			<biblScope unit="page" from="338" to="342" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Delivery materials for siRNA therapeutics</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kanasty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Dorkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vegas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Anderson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Mater</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="967" to="977" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia</title>
		<author>
			<persName><forename type="first">J</forename><surname>Astrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Symon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Branston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Lassen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="51" to="57" />
			<date type="published" when="1977">1977</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Tissuetype plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yepes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sandkvist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Bugge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Strickland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Lawrence</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="1533" to="1540" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Mitochondria-targeted antioxidant peptide SS31 prevents hypoxia/reoxygenation-induced apoptosis by downregulating p66Shc in renal tubular epithelial cells</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zeng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Physiol Biochem</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="591" to="600" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Dual role of nitric oxide in focal cerebral ischemia</title>
		<author>
			<persName><forename type="first">T</forename><surname>Dalkara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Irikura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Moskowitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="1447" to="1452" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling</title>
		<author>
			<persName><forename type="first">G</forename><surname>Schreibelt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kooij</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Reijerkerk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Van Doorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Gringhuis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Van Der Pol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Weksler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Romero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">O</forename><surname>Couraud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Piontek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">E</forename><surname>Blasig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Dijkstra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="3666" to="3676" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Early disruption of the blood-brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kastrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Groschel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Ringer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Redecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Cordesmeyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">W</forename><surname>Witte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Terborg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="2385" to="2387" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Polymorphonuclear leukocytes and monocytes/ macrophages in the pathogenesis of cerebral ischemia and stroke</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Kochanek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Hallenbeck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1367" to="1379" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
